Bio-techne corp TECH.US Overview Analysis
)TECH AI Analysis Overview
Keys for Bullish View
- Value≥4
- Dividend≥2
Analysis Conclusion
The stock has received the highest rating for its value, and its dividend score is solid. It's ideal for long-term position building. For optimal entry, check our trend or swing trading rating.
TECH Current Performance
0.79%
Bio-techne corp
3.27%
Avg of Sector
0.41%
S&P500
Top 10 High Relevance to TECH
- RVTY Revvity incValue 5Trend 1Swing Trading 2Whale Interest 3Dividend 3See more
TECH Profile
Bio-Techne Corporation is a global life sciences company providing tools and bioactive reagents for the research and clinical diagnostic communities. The Company's products assist scientific investigations into biological processes and the nature and progress of specific diseases. The Company, in partnership with Wilson Wolf, is creating products such as media and cytokines that are specifically tailored to G-Rex Bioreactors. Its segments include Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, and tissue biopsy analysis.